Effects of Tolvaptan on Volume Overload in Japanese Patients with Heart Failure: Results of a Phase II, Multicenter, Randomized, Double-blind, Placebo-controlled, Parallel-group Study

Cardiovascular Drugs and Therapy ◽

10.1007/s10557-011-6303-y ◽

2011 ◽

Vol 25 (S1) ◽

pp. 19-31 ◽

Author(s):

Masunori Matsuzaki ◽

◽

Masatsugu Hori ◽

Tohru Izumi ◽

Hidetsugu Asanoi ◽

...

Keyword(s):

Heart Failure ◽

Phase Ii ◽

Volume Overload ◽

Japanese Patients ◽

Double Blind ◽

Double Blind Placebo ◽

Parallel Group Study ◽

Parallel Group ◽

Patients With Heart Failure

Download Full-text

The efficacy and safety of lixivaptan in outpatients with heart failure and volume overload: results of a multicentre, randomized, double-blind, placebo-controlled, parallel-group study

European Journal of Heart Failure ◽

10.1093/eurjhf/hfs051 ◽

2012 ◽

Vol 14 (6) ◽

pp. 642-651 ◽

Author(s):

Jalal K. Ghali ◽

Cesare Orlandi ◽

William T. Abraham ◽

Keyword(s):

Heart Failure ◽

Volume Overload ◽

Efficacy And Safety ◽

Double Blind ◽

Double Blind Placebo ◽

Parallel Group Study ◽

Download Full-text

Heart Rate Control With If Inhibitor, Ivabradine, in Japanese Patients With Chronic Heart Failure　– A Randomized, Double-Blind, Placebo-Controlled Phase II Study –

Circulation Journal ◽

10.1253/circj.cj-15-1112 ◽

2016 ◽

Vol 80 (3) ◽

pp. 668-676 ◽

Author(s):

Hiroyuki Tsutsui ◽

Shinichi Momomura ◽

Akira Yamashina ◽

Hisao Ogawa ◽

Hiroaki Shimokawa ◽

...

Keyword(s):

Heart Failure ◽

Chronic Heart Failure ◽

Phase Ii ◽

Rate Control ◽

Phase Ii Study ◽

Japanese Patients ◽

Heart Rate Control ◽

Double Blind ◽

Double Blind Placebo

Download Full-text

Evaluation of the Efficacy and Tolerability of Combination Therapy With Candesartan Cilexetil and Amlodipine Besilate Compared With Candesartan Cilexetil Monotherapy and Amlodipine Besilate Monotherapy in Japanese Patients With Mild-to-Moderate Essential Hypertension: A Multicenter, 12-Week, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study

Clinical Therapeutics ◽

10.1016/j.clinthera.2012.02.015 ◽

2012 ◽

Vol 34 (4) ◽

pp. 838-848 ◽

Author(s):

Hiromi Rakugi ◽

Toshio Ogihara ◽

Yuko Miyata ◽

Kiyofumi Sasai ◽

Nobuo Totsuka

Keyword(s):

Essential Hypertension ◽

Combination Therapy ◽

Candesartan Cilexetil ◽

Japanese Patients ◽

Moderate Essential Hypertension ◽

Double Blind ◽

Double Blind Placebo ◽

Parallel Group Study ◽

Download Full-text

Efficacy and safety of bilastine in Japanese patients with chronic spontaneous urticaria: A multicenter, randomized, double-blind, placebo-controlled, parallel-group phase II/III study

Allergology International ◽

10.1016/j.alit.2016.08.004 ◽

2017 ◽

Vol 66 (2) ◽

pp. 317-325 ◽

Author(s):

Michihiro Hide ◽

Akiko Yagami ◽

Michinori Togawa ◽

Akihiro Saito ◽

Masutaka Furue

Keyword(s):

Phase Ii ◽

Japanese Patients ◽

Chronic Spontaneous Urticaria ◽

Efficacy And Safety ◽

Double Blind ◽

Double Blind Placebo ◽

Download Full-text

Gabapentin enacarbil in Japanese patients with restless legs syndrome: a 12-week, randomized, double-blind, placebo-controlled, parallel-group study

Current Medical Research and Opinion ◽

10.1185/03007995.2012.746217 ◽

2012 ◽

Vol 29 (1) ◽

pp. 13-21 ◽

Author(s):

Yuichi Inoue ◽

Koichi Hirata ◽

Naohisa Uchimura ◽

Kenji Kuroda ◽

Nobutaka Hattori ◽

...

Keyword(s):

Restless Legs Syndrome ◽

Japanese Patients ◽

Gabapentin Enacarbil ◽

Double Blind ◽

Double Blind Placebo ◽

Restless Legs ◽

Parallel Group Study ◽

Download Full-text

Apremilast in Patients With Active Rheumatoid Arthritis: A Phase II, Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study

Arthritis & Rheumatology ◽

10.1002/art.39120 ◽

2015 ◽

Vol 67 (7) ◽

pp. 1703-1710 ◽

Author(s):

Mark C. Genovese ◽

Katerina Jarosova ◽

Dorota Cieślak ◽

Jeffrey Alper ◽

Alan Kivitz ◽

...

Keyword(s):

Rheumatoid Arthritis ◽

Phase Ii ◽

Active Rheumatoid Arthritis ◽

Double Blind ◽

Double Blind Placebo ◽

Parallel Group Study ◽

Download Full-text

Phase II/III, randomized, double-blind, parallel-group study of monthly delayed-release versus daily immediate-release risedronate tablets in Japanese patients with involutional osteoporosis

Journal of Bone and Mineral Metabolism ◽

10.1007/s00774-019-01031-x ◽

2019 ◽

Vol 38 (1) ◽

pp. 86-98

Author(s):

Satoshi Soen ◽

Hideaki Kishimoto ◽

Hiroshi Hagino ◽

Teruki Sone ◽

Hiroaki Ohishi ◽

...

Keyword(s):

Phase Ii ◽

Japanese Patients ◽

Immediate Release ◽

Double Blind ◽

Involutional Osteoporosis ◽

Delayed Release ◽

Parallel Group Study ◽

Download Full-text

Sa2051 A Phase II, Randomized, Double-Blind, Placebo-Controlled, Multiple-Dose, Parallel-Group Study to Evaluate the Efficacy, Safety, and Pharmacodynamics of RM-131 in Patients With Chronic Constipation

Gastroenterology ◽

10.1016/s0016-5085(14)61318-4 ◽

2014 ◽

Vol 146 (5) ◽

pp. S-364 ◽

Author(s):

Andres Acosta ◽

Gururaj Kolar ◽

Johanna Iturrino ◽

Lawrence A. Szarka ◽

Amy Boldingh ◽

...

Keyword(s):

Phase Ii ◽

Chronic Constipation ◽

Multiple Dose ◽

Double Blind ◽

Double Blind Placebo ◽

Parallel Group Study ◽

Download Full-text

A randomised, double-blind, placebo controlled, parallel group study of the standardised extract SHR-5 of the roots of Rhodiola rosea in the treatment of subjects with stress-related fatigue

Planta Medica ◽

10.1055/s-0029-1235006 ◽

2009 ◽

Vol 75 (09) ◽

Author(s):

EMG Olsson ◽

B von Schéele ◽

AG Panossian

Keyword(s):

Rhodiola Rosea ◽

Double Blind ◽

Double Blind Placebo ◽

Parallel Group Study ◽

Download Full-text

Faculty Opinions recommendation of Efficacy and safety of low dose desmopressin orally disintegrating tablet in women with nocturia: results of a multicenter, randomized, double-blind, placebo controlled, parallel group study.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.717995300.793478299 ◽

2013 ◽

Author(s):

Altaf Mangera

Keyword(s):

Low Dose ◽

Efficacy And Safety ◽

Double Blind ◽

Double Blind Placebo ◽

Orally Disintegrating Tablet ◽

Parallel Group Study ◽

Download Full-text